Halozyme stockholders elect two Class III directors and approve say-on-pay at annual meeting

HALOZYME THERAPEUTICS, INC.

Jeffrey W. Henderson elected with 98,993,463 votes for, 3,298,117 against; Helen I. Torley elected with 101,477,199 for, 816,675 against.
Say-on-pay proposal approved: 98,252,464 for, 3,966,034 against, 168,127 abstain.
Ratification of Ernst & Young as 2025 auditor approved: 112,028,211 for, 659,976 against, 78,816 abstain.
Meeting held May 1, 2025; 112,767,003 shares represented out of 123,533,310 outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.